Basic and clinical immunology
Reciprocal regulation of cultured human mast cell cytokine production by IL-4 and IFN-γ

https://doi.org/10.1067/mai.2000.107043Get rights and content

Abstract

Background: TH1 and TH2 cytokines are thought to regulate allergic inflammation. Objective: Two key regulatory cytokines, IL-4 and IFN-γ, were examined for their effects on cytokine production by cultured human mast cells (CHMCs). Methods: CHMCs were obtained by culturing cord blood–derived CD34+ cells in the presence of stem cell factor and IL-6 for 14 to 16 weeks. CHMCs were passively sensitized with human myeloma IgE and supplemented with or without IL-4 or IFN-γ. After the sensitization, CHMCs were stimulated with anti-FcϵRIα mAb. Concentrations of secreted cytokines were measured by using ELISA, and cytokine messenger RNA was analyzed by using quantitative competitive RT-PCR. Results: IL-4 profoundly enhanced FcϵRI-mediated production of macrophage inflammatory protein (MIP) 1α, IL-8, and GM-CSF. For example, the enhancement by IL-4 (10 ng/mL) of the production of MIP-1α, IL-8, and GM-CSF was 25-, 7-, and 90-fold, respectively, after 6 hours. IL-4 also enhanced levels of FcϵRI-induced cytokine messenger RNA but to a lesser degree. In contrast, IFN-γ inhibited FcϵRI-induced production of MIP-1α, IL-8, and GM-CSF. For example, the inhibition by IFN-γ (10 ng/mL) of FcϵRI-mediated production of MIP-1α, IL-8, and GM-CSF was 80%, 75%, and 95%, respectively. IFN-γ also suppressed FcϵRI-induced messenger RNA expression of these cytokines. Neither IL-4 nor IFN-γ affected the kinetics of cytokine production by CHMCs. Conclusion: These data suggest that IL-4 and IFN-γ may influence allergic reactions by modulating human mast cell cytokine production. (J Allergy Clin Immunol 2000;106:141-9.)

Section snippets

Human mast cell culture

CHMCs were generated as previously reported.11, 12 In brief, heparin-treated umbilical cord blood that was obtained (under an informed consent approved by the hospital’s ethical committee) was diluted and layered over lymphocyte separation medium (Organon Teknika Corp) at room temperature. Cord blood mononuclear cells were purified by density gradient centrifugation methods followed by immunomagnetic positive selection with mAb against CD34 (Militenyi Biotec Inc). The purified CD34+ cells were

Effect of IL-4 or IFN-γ on cytokine production by CHMCs

CHMCs were incubated with IgE in the presence or absence of IL-4 for 2 days as concentration indicated. The sensitized CHMCs were washed and resuspended in mast cell culture medium containing 0 to 10 ng/mL IL-4 and 1 μg/mL CRA-1 for 6 hours. Supernatants were harvested and analyzed for various cytokines by using ELISA. IL-4 did not affect spontaneous MIP-1α production by CHMCs. FcϵRI-mediated MIP-1α production by CHMCs was 0.3 ± 0.1 ng/106 cells in the absence of IL-4 (Fig 1, A ).

. Effect of

DISCUSSION

In this study we showed that IL-4 and IFN-γ have opposite effects on human mast cell cytokine production induced by means of FcϵRI cross-linking. For example, not only does IL-4 upregulate FcϵRI-dependent production of IL-3, IL-5, and IL-13 in CHMCs or human intestinal mast cells,9, 20, 21 but it also enhances production of MIP-1α, IL-8, and GM-CSF (Fig. 1, Fig. 3). This occurs at the level of both mRNA and protein synthesis in addition to enhancement of expression of FcϵRI and FcϵRI-dependent

Acknowledgements

We thank Dr Kiyoshi Kawashima, Dr Shigenobu Shoda, and the staff of the Department of Obstetrics, Gyoda Chuo Hospital, for their continuous support by generously providing the umbilical cord blood. We also thank Dr Akira Akasawa, Dr Toshio Katsunuma, Dr Hidetoshi Kawahara, Dr Ichiro Nomura, and Mr Hisashi Tomita for their technical assistance and advice.

References (27)

  • H Toru et al.

    Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells

    J Allergy Clin Immunol

    (1998)
  • SJ Galli

    New concepts about the mast cell

    N Engl J Med

    (1993)
  • A Moller et al.

    Human mast cells produce IL-8

    J Immunol

    (1993)
  • RU Pawankar et al.

    Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis

    Am J Respir Crit Care Med

    (1995)
  • M Steffen et al.

    Presence of tumour necrosis factor or a related factor in human basophil/mast cells

    Immunology

    (1989)
  • P Bradding et al.

    Interleukin 4 is localized to and released by human mast cells

    J Exp Med

    (1992)
  • P Bradding et al.

    Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation

    J Immunol

    (1993)
  • P Bradding et al.

    Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines

    Am J Respir Cell Mol Biol

    (1994)
  • P Bradding et al.

    Heterogeneity of human mast cells based on cytokine content

    J Immunol

    (1995)
  • SC Bischoff et al.

    IL-4 enhances proliferation and mediator release in mature human mast cells

    Proc Natl Acad Sci USA

    (1999)
  • R Pawankar et al.

    Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the FcϵRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells

    J Clin Invest

    (1997)
  • H Saito et al.

    Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells

    J Immunol

    (1996)
  • H Tachimoto et al.

    Activation human mast cells release factors supporting eosinophil survival in vitro

    Int Arch Allergy Immunol

    (1997)
  • Cited by (35)

    • Identification of a lysophosphatidylserine receptor on mast cells

      2006, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      After 4 weeks of culture, >98% of the cells were mast cells as demonstrated by staining with Alcian blue and safranin. Cultured human mast cells (CHMCs) were generated as previously described [22–24]. Briefly, mononuclear cells were separated from umbilical cord blood samples derived from three healthy mothers using density gradient centrifugation followed by immunomagnetic positive selection with mAb against CD34 (MACS II; Miltenyi Biotech, Bergisch Gladbach, Germany).

    • High-resolution tracking of cell division demonstrates differential effects of T<inf>H</inf>1 and T<inf>H</inf>2 cytokines on SCF-dependent human mast cell production in vitro: Correlation with apoptosis and Kit expression

      2005, Blood
      Citation Excerpt :

      Although IFN-γ and IL-5 had no effect on human mast cell mediator release, IL-4 potentiated spontaneous and antigen-stimulated β-hexosaminidase release by approximately 40% (Figure 5B). The increase in releasability seen in cultures exposed to IL-4 was accompanied by an increase in FcϵRI expression, consistent with previous reports (data not shown;14). Thus, of the TH1 and TH2 cytokines examined, IL-4 was one cytokine that clearly enhanced mast cell function when added for the first time late in cultures.

    View all citing articles on Scopus

    Reprint requests: Motohiro Ebisawa, MD, PhD, Department of Allergy, National Children’s Medical Research Center 3-35-31, Taishido, Setagaya-ku, Tokyo, 154-8509, Japan.

    View full text